Radiotherapy & Oncology
Volume 97, Issue 2 , Pages 217-224, November 2010

Dynamic contrast-enhanced magnetic resonance imaging of human cervical carcinoma xenografts: Pharmacokinetic analysis and correlation to tumor histomorphology

Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, Norway

Received 24 December 2009; received in revised form 10 June 2010; accepted 22 June 2010. published online 26 July 2010.

Abstract 

Background and purpose

Biomarkers that can predict the outcome of treatment accurately are needed for treatment individualization in advanced carcinoma of the uterine cervix. The potential of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) was investigated in the present preclinical study.

Materials and methods

CK-160 and TS-415 human cervical carcinoma xenografts were subjected to DCE-MRI at 1.5T using a spatial resolution of 0.23×0.47×2.0mm3. Parametric images of Ktrans (the volume transfer constant of Gd-DTPA) and ve (the extravascular extracellular volume fraction) were produced by pharmacokinetic analysis of the DCE-MRI data and compared with the histomorphology of the imaged tissue.

Results

Analysis of small homogeneous tumor regions showed that Ktrans, but not ve, differed significantly between parenchymal tissue, connective tissue, and necrotic tissue, consistent with the vascularity of these compartments. However, strong correlations between Ktrans and the fractional volume of the compartments could not be detected for larger tumor regions, primarily because the majority of the voxels represented a chaotic mixture of parenchymal, connective, and necrotic tissue.

Conclusion

The potential of DCE-MRI in providing detailed information on the histomorphology of cervical carcinoma is limited, mainly because the tumor tissue shows significant morphological heterogeneity at the subvoxel level.

Keywords: Cervical carcinoma xenografts, Histomorphology, Magnetic resonance imaging

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0167-8140(10)00398-1

doi:10.1016/j.radonc.2010.06.011

Radiotherapy & Oncology
Volume 97, Issue 2 , Pages 217-224, November 2010